Literature DB >> 10751042

Development and characterization of a rapid and comprehensive genotyping assay to detect the most common variants in cytochrome P450 2D6.

L A Scarlett1, S Madani, D D Shen, R J Ho.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10751042     DOI: 10.1023/a:1007585801905

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  15 in total

1.  Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.

Authors:  A K Daly; M Armstrong; S C Monkman; M E Idle; J R Idle
Journal:  Pharmacogenetics       Date:  1991-10

2.  10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes.

Authors:  P Dalén; M L Dahl; M L Bernal Ruiz; J Nordin; L Bertilsson
Journal:  Clin Pharmacol Ther       Date:  1998-04       Impact factor: 6.875

Review 3.  Gene chips: array of hope for understanding gene regulation.

Authors:  M Johnston
Journal:  Curr Biol       Date:  1998-02-26       Impact factor: 10.834

4.  CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.

Authors:  D Köhler; S Härtter; K Fuchs; W Sieghart; C Hiemke
Journal:  Pharmacogenetics       Date:  1997-12

5.  Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

Authors:  C Sachse; J Brockmöller; S Bauer; I Roots
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

6.  Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.

Authors:  S V Otton; H K Crewe; M S Lennard; G T Tucker; H F Woods
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

Review 7.  Pharmacogenetic phenotyping and genotyping. Present status and future potential.

Authors:  F J Gonzalez; J R Idle
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

8.  PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates.

Authors:  W M Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

9.  Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.

Authors:  S Madani; M F Paine; L Lewis; K E Thummel; D D Shen
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

10.  Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology.

Authors:  V M Steen; O A Andreassen; A K Daly; T Tefre; A L Børresen; J R Idle; A K Gulbrandsen
Journal:  Pharmacogenetics       Date:  1995-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.